Article info

Download PDFPDF

Original research
SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry

Authors

  • Saskia Lawson-Tovey Centre for Genetics and Genomics Versus Arthritis, The University of Manchester, Manchester, UKNational Institute of Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, UK PubMed articlesGoogle scholar articles
  • Pedro M Machado Centre for Rheumatology & Department of Neuromuscular Diseases, University College London, London, UKNational Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK PubMed articlesGoogle scholar articles
  • Anja Strangfeld Epidemiology Unit, German Rheumatism Research Center Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Elsa Mateus Portuguese League Against Rheumatic Diseases (LPCDR), Lisbon, PortugalStanding Committee of People with Arthritis/Rheumatism in Europe (PARE), European League Against Rheumatism, Zurich, Switzerland PubMed articlesGoogle scholar articles
  • Laure Gossec INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Sorbonne Universite, Paris, FranceAPHP, Rheumatology Department, Hopital Universitaire Pitie Salpetriere, Paris, France PubMed articlesGoogle scholar articles
  • Loreto Carmona Instituto de Salud Musculoesquelética, Madrid, Spain PubMed articlesGoogle scholar articles
  • Bernd Raffeiner Department of Rheumatology, Central Hospital of Bolzano, Bolzano, Italy PubMed articlesGoogle scholar articles
  • Inita Bulina Rheumatology Department, Paul Stradins Clinical University Hospital, Riga, LatviaRiga Stradins University, Riga, Latvia PubMed articlesGoogle scholar articles
  • Daniel Clemente Paediatric Rheumatology Department, Hospital Niño Jesús, Madrid, Spain PubMed articlesGoogle scholar articles
  • Julija Zepa Riga Stradins University, Riga, LatviaPaul Stradins Clinical University Hospital, Riga, Latvia PubMed articlesGoogle scholar articles
  • Ana M. Rodrigues Reuma.pt, Sociedade Portuguesa de Reumatologia, Lisboa, PortugalEpiDoC unit, CEDOC, Nova Medical School, Lisboa, Portugal PubMed articlesGoogle scholar articles
  • Xavier Mariette Rheumatology, Universite Paris-Saclay, Assitance Publique-Hopitaux de Paris, INSERM UMR1184, Hopital Bicetre, Le Kremlin-Bicetre, France PubMed articlesGoogle scholar articles
  • Kimme L Hyrich National Institute of Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, UKCentre for Epidemiology Versus Arthritis, The University of Manchester, Manchester, UK PubMed articlesGoogle scholar articles
  • EULAR COVAX
    Google scholar articles
  1. Correspondence to Prof Kimme L Hyrich; kimme.hyrich{at}manchester.ac.uk
View Full Text

Citation

Lawson-Tovey S, Machado PM, Strangfeld A EULAR COVAX, et al
SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry

Publication history

  • Received March 8, 2022
  • Accepted July 15, 2022
  • First published July 31, 2022.
Online issue publication 
July 31, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.